https://www.news-medical.net/news/20230223/Clec9A-RBD-immunization-could-trigger-robust-and-sustained-systemic-and-mucosal-immune-responses-against-rapidly-evolving-SARS-CoV-2-variants.aspx
0
0
Clec9A-RBD immunization could trigger robust and sustained systemic and mucosal immune responses against rapidly evolving SARS-CoV-2 variants - News-Medical.Net
2/23/23 at 2:41am
Organization
News-Medical.Net
Authors
Details
42 words
Summarize
Infectious Diseases Public Health Medical Procedures Public Safety RBD anti-SARS-CoV-2 dendritic cell vaccine candidate
Researchers assessed the impact of a single-dose dendritic cell vaccine candidate on immune responses against SARS-CoV-2.
Create an account or login to join the discussion